Influence of psychiatric comorbidity on recovery and recurrence in generalized anxiety disorder, social phobia, and panic disorder: A 12-year prospective study

Harvard University, Cambridge, Massachusetts, United States
American Journal of Psychiatry (Impact Factor: 13.56). 07/2005; 162(6):1179-87. DOI: 10.1176/appi.ajp.162.6.1179
Source: PubMed

ABSTRACT The authors sought to observe the long-term clinical course of anxiety disorders over 12 years and to examine the influence of comorbid psychiatric disorders on recovery from or recurrence of panic disorder, generalized anxiety disorder, and social phobia.
Data were drawn from the Harvard/Brown Anxiety Disorders Research Program, a prospective, naturalistic, longitudinal, multicenter study of adults with a current or past history of anxiety disorders. Probabilities of recovery and recurrence were calculated by using standard survival analysis methods. Proportional hazards regression analyses with time-varying covariates were conducted to determine risk ratios for possible comorbid psychiatric predictors of recovery and recurrence.
Survival analyses revealed an overall chronic course for the majority of the anxiety disorders. Social phobia had the smallest probability of recovery after 12 years of follow-up. Moreover, patients who had prospectively observed recovery from their intake anxiety disorder had a high probability of recurrence over the follow-up period. The overall clinical course was worsened by several comorbid psychiatric conditions, including major depression and alcohol and other substance use disorders, and by comorbidity of generalized anxiety disorder and panic disorder with agoraphobia.
These data depict the anxiety disorders as insidious, with a chronic clinical course, low rates of recovery, and relatively high probabilities of recurrence. The presence of particular comorbid psychiatric disorders significantly lowered the likelihood of recovery from anxiety disorders and increased the likelihood of their recurrence. The findings add to the understanding of the nosology and treatment of these disorders.


Available from: Maria E Pagano, May 01, 2015
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Despite the high comorbidity of Social Anxiety Disorder (SAD) and Major Depressive Disorder (MDD), we know little about how persons with co-occurring SAD–MDD compare to their counterparts with pure disorders. In the present study we investigated attention to facial emotional stimuli in adult women with SAD only (n = 18), MDD only (n = 24), co-occurring SAD–MDD (n = 24), and healthy controls (CTL; n = 33). Participants were exposed to angry, sad, neutral, and happy faces for 200 and 1,000 ms as cues in a Posner attention task. We examined patterns of attentional engagement, disengagement, and vigilance-avoidance as a function of cue valence. Across the attentional indices, both the SAD and SAD–MDD groups differed most consistently from the MDD and CTL groups: they exhibited differential patterns of attention to angry, sad, and happy faces, including relatively greater vigilance-avoidance for angry faces. There was little evidence for any MDD-associated biases in attention. Findings suggest that the attentional processing of emotional information in SAD generally overrides the potential influence of co-occurring MDD. Implications for the understanding and treatment of co-occurring SAD–MDD are discussed.
    Cognitive Therapy and Research 04/2015; 39(2):153-161. DOI:10.1007/s10608-014-9643-7 · 1.70 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Anxiety disorders commonly co-occur with substance use disorders both in the general population and in treatment-seeking samples. This co-occurrence is associated with greater symptom severity, higher levels of disability, and poorer course of illness relative to either disorder alone. Little research has been conducted, however, on the treatment of these co-occurring disorders. This gap may not only leave anxiety untreated or undertreated but also increase the risk for relapse and poor substance use outcomes. The aim of this article is to review the current state of the literature on treating co-occurring anxiety and substance use disorders. In addition to presenting a brief overview of the epidemiology of this co-occurrence, the article discusses the challenges in assessing anxiety in the context of a substance use disorder, the evidence for various treatment approaches, and recent advances and future directions in this understudied area. Also highlighted is the need for future research to identify optimal behavioral and pharmacologic treatments for co-occurring anxiety and substance use disorders.
    Harvard Review of Psychiatry 03/2015; 23(2):99-111. DOI:10.1097/HRP.0000000000000058 · 2.49 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Cognitive behavior therapy (CBT) is the treatment of choice in anxiety disorders. However, there is little evidence for the effectiveness brief CBT in social anxiety. We examined the effectiveness of a brief CBT of six sessions in patients with social anxiety disorder. A single case design study baseline; post and 1 month follow-up was adopted. Seven patients with a DSM IV diagnosis of social anxiety underwent 6 weekly sessions of brief CBT. Their diagnosis was confirmed using structured diagnostic interviews. They were assessed at baseline, post and 1-month follow-up on CGI- Severity, Leibowitz Social Anxiety Scale (LSAS), Social Phobia Rating Scale, Brief Fear of Negative Evaluation, and Beck's Depression Inventory. Data were analyzed using the method of clinical significance. Results indicated that brief CBT was effective in reducing social anxiety in all patients. Brief CBT was also effective in reducing social avoidance and self consciousness. However, brief CBT was not effective in reducing fear of negative evaluation in all patients, suggesting the need for longer duration for cognitive changes in some dysfunctional beliefs. This preliminary case series indicates that brief CBT may be a promising and a cost and time effective approach to managing for social anxiety.
    Indian Journal of Psychological Medicine 01/2015; 37(1):20-5. DOI:10.4103/0253-7176.150808